Breaking AI & Tech News Analyzed

The Tyre hospital in Lebanon has faced significant challenges, being hit five times since the start of Israel's attacks on the country. This escalation of violence has raised concerns about the humanitarian situation in the region.The repeated strikes on the hospital have likely disrupted medical services and put the lives of patients and staff at risk. The situation remains volatile, with ongoing tensions between Israel and Lebanon contributing to the uncertainty.

Palantir’s senior UK representative has warned ministers against yielding to ideologically motivated campaigners as they explore the possibility of terminating a £330 million NHS contract for the company’s Federated Data Platform (FDP).The FDP, an AI‑enabled system intended to unify patient information across the health service, is part of a broader portfolio that includes contracts with the Ministry of Defence, several police forces and the UK’s financial regulator.Louis Mosley, executive vice‑chair of Palantir UK, told The Times that abandoning the deal would jeopardise patient care and hinder progress on the NHS’s most pressing challenges. He highlighted that the platform is projected to generate £150 million in benefits by the end of the decade, delivering a £5 return for every pound spent.According to the Financial Times, senior officials have begun informal discussions about activating a break clause that would allow the FDP’s operation to be transferred to an alternative provider once the system becomes fully operational next year.Palantir, a US‑based data‑analytics firm with ties to the Israeli and US militaries and former U.S. Immigration and Customs Enforcement contracts, has faced sustained opposition from the British Medical Association, which has long criticised the use of its technology in patient‑care settings.Health officials acknowledge the reputational risk, noting that the controversy now extends beyond traditional Labour‑left and Green Party critics. A Department of Health and Social Care spokesperson emphasised that the FDP is designed to improve care coordination, accelerate cancer diagnoses and increase treatment capacity, while maintaining strict data‑security safeguards.Health Secretary Wes Streeting, speaking on the Guardian Politics Weekly podcast, recognised public unease about Palantir’s political affiliations, referencing founder Peter Thiel’s right‑wing connections. He reassured listeners that Palantir does not have direct access to patient data, stating, "The platform is operated by us; Palantir never sees the data."Adoption of Palantir’s technology within the NHS has risen from 118 to 151 organisations since June, though it remains short of the government’s target of 240 organisations by year‑end. Labour backbencher Clive Lewis noted that the issue is becoming a visible concern for voters, reflecting broader anxieties about AI and foreign‑owned infrastructure in critical public services.

The tragic case of Oliver Robinson, a 34-year-old who took his own life in November 2023, has sparked a campaign for stricter controls on private cannabis clinics in the UK. An inquest concluded that Robinson's prescription for medicinal cannabis, issued by Curaleaf Clinic, probably contributed to his death and acted as an obstacle to him receiving proper psychiatric and addiction care. Robinson had been struggling with depression and addiction, and had been treated at the Priory, a private mental health facility. He was initially prescribed medicinal cannabis in May 2022, which initially provided relief but ultimately worsened his condition. The coroner's report highlighted several failings in his care, including the use of an out-of-date GP summary care record and incomplete information in prescribing decisions. Alexander Robinson, Oliver's brother, is now advocating for tighter regulation of private cannabis clinics, including a ban on prescribing to patients with serious mental illness and greater oversight of the rapidly expanding industry. He believes that the current safeguards are not strong enough to protect vulnerable psychiatric patients. The UK government reported about 5,000 NHS prescriptions for licensed cannabis-based medicinal products in 2023, while freedom of information data showed that 659,293 unlicensed cannabis products were privately prescribed in 2024, more than double the number issued in 2023. Critics argue that there is limited evidence that cannabis is an effective treatment for depression and other common mental health conditions. Dr. Pavan Chahl, an expert psychiatrist, told Oliver's inquest that medicinal cannabis should not have been prescribed to someone with a history of severe psychiatric disorder, citing a lack of evidence for efficacy in depression and the risk of worsening symptoms. In response to the campaign, Curaleaf Clinic stated that it would engage constructively with any review or consultation aimed at strengthening patient safety across the sector.

In Mexico, a mother's determination to navigate the country's beleaguered cancer care system has become a defining feature of her daily life. Faced with a healthcare system in crisis, she finds herself unceasingly vigilant in her quest for adequate treatment.The situation in Mexico's healthcare sector is marked by significant challenges, particularly in the realm of cancer care. Patients and families are often left to struggle with accessing timely and effective treatment, leading to a heavy emotional and financial toll.For this mother, the reality of her child's health battle is a harsh reminder of the system's shortcomings. Her story serves as a poignant example of the human cost of healthcare deficiencies and the resilience of those affected.

Eli Lilly, the US pharmaceutical group behind the Mounjaro weight-loss drug, is seeking to resume its investments in the UK after pausing them last year. The company is in talks with UK ministers to regularly increase NHS drug prices and end a rebate scheme. Patrik Jonsson, president of Eli Lilly's international business, expressed optimism about reaching an agreement this summer.The talks will also explore 'innovative' pricing plans, such as linking payments for anti-obesity drugs to whether the treatment helps patients return to work. This comes as the US pharmaceutical industry increases pressure on the UK, with Keir Starmer agreeing to the first increase in NHS cost-effectiveness thresholds in 27 years. The threshold was raised from £20,000 to £30,000 a year for every year of life gained to £25,000 to £35,000.Eli Lilly was one of several pharmaceutical companies that ditched or paused almost £25bn in planned investments in the UK last year. The company paused its plans to invest in a laboratory site in central London. Jonsson stated that the resumption of Eli Lilly's investment would depend on the outcome of its talks with the government.He emphasized that prices for medicines in the UK had been 'far too low for far too long' and that the threshold couldn't remain static for another three decades. The UK agreed to pay 25% more for new medicines by 2035 as part of a US-UK drug pricing deal, which could eventually reach £9bn a year.Large pharmaceutical companies have protested about a 'rebate' scheme, under which they are required to pay back a chunk of revenue from sales of branded medicines. This scheme is expected to fall in 2026, although Jonsson believes payments 'should actually get down to zero' over time.

Australian GPs are increasingly turning to AI scribes to record patient notes, with 40% now using the technology, according to a Royal Australian College of GPs (RACGP) online poll. This represents a significant increase from 22% in August 2024.AI tools, such as those offered by Australian company Heidi, record, transcribe, and summarize conversations between doctors and patients for medical notes. Dr. Max Mollenkopf, a GP based in Newcastle, emphasizes the importance of transparency with patients, stating, “We make a big effort to let patients know we are using AI, and give them the option to opt out.”While AI scribes can help relieve doctors' administrative burden, experts point to concerns about consent, privacy, and accuracy. Dr. Elizabeth Deveny, chief executive of the Consumer Health Forum, notes that not all practices are having explicit conversations about the tools with patients.Some GPs see AI scribes as a way to better connect with patients during consultations, allowing them to focus on the patient directly rather than typing notes. However, Dr. Caitlin Curtis, a University of Queensland researcher, warns that outsourcing note-keeping to AI may lead to doctors failing to retain and recall patient conversations.The RACGP president, Dr. Michael Wright, is optimistic about AI tools helping patients and GPs work more closely together, but emphasizes the need for patient consent and verification of AI output. Heidi co-founder Dr. Tom Kelly assures that data is processed securely and not used to train the AI or sold to others.

The UK is on the brink of a medicine shortage crisis, with experts warning that the country is just weeks away from feeling the effects of the ongoing conflict in Iran. The war has already disrupted the supply of essential raw materials, including oil, gas, crop fertiliser, and helium.The pharmaceutical industry, which relies heavily on imports, is particularly vulnerable to these disruptions. India, known as the 'pharmacy of the world', produces a significant proportion of generic drugs and active pharmaceutical ingredients (APIs) used globally. However, with the Strait of Hormuz largely closed due to the conflict, the transportation of these vital supplies is becoming increasingly difficult.Medicine prices are also expected to rise as a result of the conflict. The US-Israel war on Iran has doubled air freight costs, which could make some medicines loss-making to supply to the NHS. While suppliers have long-term pricing agreements with NHS hospitals, they have more flexibility to increase prices for drugs supplied to GP practices and pharmacies.The UK's reliance on imported medicines is significant, with about half of its medicines produced domestically, a third coming from India, and another chunk from the EU. During the Covid pandemic, paracetamol and other painkillers were in short supply in Britain and elsewhere, as drugmakers in India struggled to keep up with demand.Medical distributors typically stock six to eight weeks of supplies to avoid shortfalls, but if the conflict drags on, drug shortages could emerge in only a few weeks' time. Experts warn that the overall ripple effect on the industry is significant, with the patient ultimately picking up the tab, either directly or via public health systems like the NHS.

New York City's public hospital system has announced that it will not be renewing its contract with Palantir, a data analytics and AI firm, amid growing controversy over its government contracts in the UK. The decision comes as health officials in the UK express concerns over data privacy issues related to Palantir's £330m agreement with the National Health Service (NHS).The contract between NYC Health + Hospitals and Palantir, which focused on recovering money for insurance claims, was set to expire in October. According to documents shared with the Guardian, Palantir has paid nearly $4m to the hospital system since November 2023. The contract allowed Palantir to review patient health notes and help the hospital claim more money in public benefits through programs like Medicaid.Despite assurances from NYC Health + Hospitals that there was an 'absolute firewall' preventing Palantir from sharing information with US Immigration and Customs Enforcement (ICE), activists and data privacy experts have raised concerns over the potential risks of Palantir accessing de-identified patient data for purposes other than research.As New York City prepares to part ways with Palantir, the company is expanding its influence in the UK, despite backlash from activists and lawmakers. Palantir has contracts with the British government's Ministry of Defence and is seeking access to sensitive national financial regulation data through a contract with the Financial Conduct Authority.Medact, a health justice charity, has raised concerns that Palantir's software could enable 'data-driven state abuses of power', including US-style ICE raids. In response, Palantir has denied that its data could be used in this way, citing that it would be illegal and a breach of contract.The decision by NYC Health + Hospitals to drop Palantir has been hailed as a victory by activists, who are now calling on the NHS to follow suit and terminate its £330m contract with the company. The 'Purge Palantir' campaign, which involves nurses, pro-Palestinian activists, and social and climate justice groups, aims to stop Palantir from contracting with government agencies, universities, and corporations.

The World Health Organization (WHO) has issued a dire warning about a health crisis unfolding in real time across the Middle East, emphasizing the urgent need for a complete cessation of hostilities to mitigate the humanitarian catastrophe.Dr. Hanan Balkhy, the WHO's regional director for the Eastern Mediterranean, stressed that hospitals and healthcare facilities must be treated as safe havens to protect patients and healthcare workers. The region, encompassing 22 countries and territories including Iran, Gulf states, Gaza, Sudan, Afghanistan, and Pakistan, is facing severe disruptions in healthcare services due to the ongoing conflicts.The violence has resulted in significant loss of life and displacement, with over 1,000 people killed in Lebanon, 1,500 in Iran, and 16 in Israel, alongside reports of numerous deaths in the West Bank and Gulf Arab states. Moreover, 3.2 million people have been displaced in Iran and over 1 million in Lebanon within a month, exacerbating the crisis.Balkhy expressed deep concern about the long-term impacts on maternal mortality, mental health, and the plight of orphaned children left without education. The WHO has verified dozens of attacks on healthcare facilities in Lebanon, Iran, and Israel since the conflict began, including a recent attack on a hospital in Sudan that killed at least 70 people.The organization is also preparing for potential attacks on nuclear sites and water desalination plants, which could have catastrophic health repercussions. Balkhy urged for a significant de-escalation or a permanent pause in hostilities to prevent further humanitarian disaster.